Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-29T12:43:45.393Z Has data issue: false hasContentIssue false
  • English
  • Français

Hepatitis B Vaccination in Psychiatric patients in Morocco

Published online by Cambridge University Press:  19 July 2023

B. Zineb ,
T. Aicha ,
K. Imane ,
L. Fouad  and
O. Abderrazak
B. Zineb*
Affiliation:
Ar-razi psychiatric hospital, Faculty of Medecine and Pharmacy
T. Aicha
Affiliation:
Ar-razi Psychiatric hospital, Rabat, Morocco
K. Imane
Affiliation:
Ar-razi psychiatric hospital, Faculty of Medecine and Pharmacy
L. Fouad
Affiliation:
Ar-razi psychiatric hospital, Faculty of Medecine and Pharmacy
O. Abderrazak
Affiliation:
Ar-razi psychiatric hospital, Faculty of Medecine and Pharmacy
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Severe mental illnesses such as schizophrenia, bipolar disorder and depressive disorder are common worldwide and often have a chronic course.

Due to psychiatric ( for example : substance use disorders ) and somatic ( for example : obesity, cardiovascular disease, diabetes ) comorbidities, mortality is higher in these patients than in the general population.Viral diseases are, in addition to cardiovascular diseases and metabolic alterations, among the most common somatic comorbidities in people with severe mental illness.

Objectives

The objective of our work was to study the prevalence of vaccination against the viral hepatitis B virus in these patients.

Methods

For this purpose, we conducted a cross-sectional study of 200 patients hospitalized in the emergency department of our training center. First, we collected sociodemographic and clinical data on patients admitted to psychiatric emergencies: sex, age, diagnosis, duration of evolution, history (medical and surgical, psychiatric, suicide attempts, problematic substance use, previous incarceration). In a second step, we tested for anti-HBS antibodies.

Results

the majority of our patients were male, the first diagnosis was schizophrenia.

92% of our patients had a substance use disorder, mainly tobacco, followed by cannabis and then alcohol.

Several patients reported having unprotected sex.

58% of patients were vaccinated against hepatitis B, these patients were young for the most part. the majority of our patients were male, the first diagnosis was schizophrenia.92% of our patients had a substance use disorder, mainly tobacco, followed by cannabis and then alcohol.Several patients reported having unprotected sex.58% of patients were vaccinated against hepatitis B, these patients were young for the most part.

Conclusions: Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S753 - S754
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.